Lenalidomide enantiomer supercritical fluid chromatographic separation method
A supercritical fluid, enantiomer technology, applied in the field of chiral chromatographic separation, to achieve the effect of good separation effect and short separation time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1~12
[0029] The supercritical fluid chromatography separation method of embodiment 1~12 lenalidomide enantiomer
[0030] In the supercritical fluid chromatographic separation method of embodiment 1~12, the chromatograph that selects is Waters Acquity ultra-efficient converging chromatographic system (Ultra Performance Convergence Chromatography, UPC 2 ), the chromatographic column size is 150 mm×4.6 mm, and the mobile phase flow rate is 2.5 mL min -1 , the concentration of lenalidomide is 0.5 mg·mL -1 , the injection volume was 10 μL, and the detection wavelength was 220 nm.
[0031] Table 1 shows the remaining relevant conditions and corresponding separation results selected by the supercritical fluid chromatography separation method of lenalidomide enantiomers in Examples 1-12. Among them, Enantiopak AD represents the chiral stationary phase of amylose coated with three (3,5-dimethylphenylcarbamoylated) on the surface of silica gel; Formylated) amylose chiral stationary phase;...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com